Salubrinal treats the non-alcoholic fatty liver disease through eIF2α signaling pathway #br#
ZHANG Shi-qi, LIU Da-quan, LI Xin-le, ZHANG Ping, △
Tianjin Medical Journal . 2020, (5): 375 -380 .  DOI: 10.11958/20193736